NeuroPace, Inc. (NASDAQ:NPCE) Q1 2024 Earnings Call Transcript
Operator: Good afternoon and welcome to NeuroPace's First Quarter 2024 Conference Call. As a reminder, this call is being recorded.
Neuropace Inc (NPCE)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | OrbiMed Advisors Samuel Isaly | 4,003,967 | $52,852,364 | 0.96% | |
| 2. | Soleus Capital Guy Levy | 2,433,168 | $32,117,818 | 2.38% | |
| 3. | Nantahala Capital Management Wilmot B. Harkey And Daniel Mack | 778,260 | $10,273,032 | -34% | 0.58% |
| 4. | Kent Lake Capital Benjamin Natter | 643,629 | $8,495,903 | -5% | 3.7% |
| 5. | Millennium Management Israel Englander | 605,713 | $7,995,412 | +252% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.50 | 62,398 | Large Shareholder | 4,432,948 | 2022-11-22 | Filing | |
| $1.50 | 327,893 | Large Shareholder | 4,370,550 | 2022-11-21 | Filing | |
| $17.00 | 235,000 | Large Shareholder | 235,000 | 2021-04-21 | Filing | |
| $17.00 | 2,352 | Officer | 2,352 | 2021-04-21 | Filing | |
| $17.00 | 588,235 | Large Shareholder | 588,235 | 2021-04-21 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $14.03 | 4,674 | Large Shareholder | 3,406,335 | 2024-05-03 | Filing | |
| $14.01 | 8,842 | Large Shareholder | 3,411,009 | 2024-05-02 | Filing | |
| $14.02 | 15,690 | Large Shareholder | 3,419,851 | 2024-05-01 | Filing | |
| $14.06 | 1,781 | Large Shareholder | 3,435,541 | 2024-04-24 | Filing | |
| $14.29 | 21,791 | Large Shareholder | 3,437,322 | 2024-04-23 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 2,460,716 | $25,369,982 | 0% | |
| 2. | 468,081 | $4,825,915 | 0% | |
| 3. | 413,106 | $4,259,123 | 0% | |
| 4. | 115,996 | $1,196,166 | 0% | |
| 5. | 86,502 | $891,835 | 0% |
News See All
NeuroPace, Inc. (NASDAQ:NPCE) Q4 2023 Earnings Call Transcript
NeuroPace, Inc. beats earnings expectations. Reported EPS is $-0.23, expectations were $-0.33.
20 Most Valuable Digital Health Companies In The US
In this article, we will be taking a look at the 20 most valuable digital health companies in the US.
NeuroPace, Inc. (NASDAQ:NPCE) Q3 2023 Earnings Call Transcript
Operator: Ladies and gentlemen, greetings and welcome to the NeuroPace, Inc. Third Quarter 2023 Earnings Conference Call. [Operator Instructions] As a reminder, this conference is being recorded.
12 Best Performing NASDAQ Stocks in 2023
In this piece, we will take a look at the 12 best performing NASDAQ stocks in 2023.
20 Countries With Highest Rate of Epilepsy
In this article, we will take a detailed look at the 20 countries with the highest rates of epilepsy with insights into number of epilepsy cases by country and population.
NeuroPace, Inc. (NASDAQ:NPCE) Q2 2023 Earnings Call Transcript
Operator: Good afternoon and welcome to NeuroPace's Second Quarter 2023 Earnings Conference Call. As a reminder, this conference is being recorded.
NeuroPace, Inc. (NASDAQ:NPCE) Q1 2023 Earnings Call Transcript
Operator: Good afternoon, and welcome to NeuroPace's First Quarter Earnings Conference Call. At this time, all participants are in a listen-only mode.
NeuroPace, Inc. (NASDAQ:NPCE) Q4 2022 Earnings Call Transcript
Operator: Good afternoon, and welcome to NeuroPace's Fourth Quarter Earnings Conference Call. At this time, all participants are in a listen-only mode.
NeuroPace, Inc. (NASDAQ:NPCE) Q3 2022 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Q3 2022 NeuroPace earnings conference call. . Please be advised that today's conference is being recorded.